Literature DB >> 10713676

Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death.

A Suzuki1, T Ito, H Kawano, M Hayashida, Y Hayasaki, Y Tsutomi, K Akahane, T Nakano, M Miura, K Shiraki.   

Abstract

Caspase 3 is an essential death factor for the Fas-mediated cell death, and its inactivation in cells is initiated by an interaction with p21 on mitochondria or with IAP family member ILP. Survivin is also a member of IAP family and is specifically expressed during embryogenesis and in tumor cells and suppresses cell death signaling. In our current study, we demonstrated that Survivin translocation into the nucleus is dependent on Fas stimulation and cell proliferation. Survivin also interacts with the cell cycle regulator Cdk4, leading to Cdk2/Cyclin E activation and Rb phosphorylation. As a result of Survivin/Cdk4 complex formation, p21 is released from its complex with Cdk4 and interacts with mitochondrial procaspase 3 to suppress Fas-mediated cell death. Here, we propose that Survivin supports procaspase 3/p21 complex formation as a result of interaction with Cdk4 resulting in suppression of cell death signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713676     DOI: 10.1038/sj.onc.1203429

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  73 in total

1.  PKB phosphorylation and survivin expression are cooperatively regulated by disruption of microfilament cytoskeleton.

Authors:  Yu-Long Liang; Li-Ying Wang; Heng Wu; Dong-Zhu Ma; Zhen Xu; Xi-Liang Zha
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

2.  Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2.

Authors:  Jian-Guo Qiao; Yu-Qing Zhang; Yu-Chun Yin; Zui Tan
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

Review 3.  Survivin and leukemia.

Authors:  Xiu Li Cong; Zhong Chao Han
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

4.  Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721.

Authors:  Sheng-Quan Cheng; Wen-Liang Wang; Wei Yan; Qing-Long Li; Li Wang; Wen-Yong Wang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

5.  Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.

Authors:  Shunzeng Lv; Ekaterina Turlova; Shigang Zhao; Huihui Kang; Mingzhi Han; Hong-Shuo Sun
Journal:  Tumour Biol       Date:  2013-10-08

Review 6.  Prognostic value of survivin expression in breast cancer patients: a meta-analysis.

Authors:  Jian Song; Hong Su; Yang-Yang Zhou; Liang-Liang Guo
Journal:  Tumour Biol       Date:  2013-05-21

7.  Aurora B prevents delayed DNA replication and premature mitotic exit by repressing p21(Cip1).

Authors:  Marianna Trakala; Gonzalo Fernández-Miranda; Ignacio Pérez de Castro; Christopher Heeschen; Marcos Malumbres
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

8.  Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells.

Authors:  Jin-bo Wang; Li-li Qi; Shui-di Zheng; Tian-xing Wu
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

9.  Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2.

Authors:  Marcus Kernt; Aljoscha S Neubauer; Kirsten H Eibl; Armin Wolf; Michael W Ulbig; Anselm Kampik; Cristoph Hirneiss
Journal:  Clin Ophthalmol       Date:  2010-07-21

10.  Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells.

Authors:  Baoan Chen; Yiqiong Liang; Weiwei Wu; Jian Cheng; Guohua Xia; Feng Gao; Jiahua Ding; Chong Gao; Zeye Shao; Guohong Li; Wenji Chen; Wenlin Xu; Xinchen Sun; Lijie Liu; Xiaomao Li; Xuemei Wang
Journal:  Int J Nanomedicine       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.